Plerixafor
Showing 176 - 182 of 182
Acute Myelogenous Leukemia, MDS Trial (AMD3100, Allogeneic Stem Cell Transplantation)
Withdrawn
- Acute Myelogenous Leukemia
- Myelodysplastic Syndromes
- AMD3100
- Allogeneic Stem Cell Transplantation
- (no location specified)
Feb 10, 2014
Prospective Observational Study on Plerixafor After Chemotherapy
Completed
- Lymphoma
- Myeloma
- plerixafor
-
Milan, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Oct 2, 2012
End Stage Liver DIsease Trial in Newark (Mobilization with G-CSF and Mozobil)
Unknown status
- End Stage Liver DIsease
- Mobilization with G-CSF and Mozobil
-
Newark, New JerseyUniversity of Medicine and Dentistry of New Jersey
Jan 23, 2013
Neutropenia Trial in Seattle (AMD3100 or plerixafor)
Completed
- Neutropenia
- AMD3100 or plerixafor
-
Seattle, WashingtonUniversity of Washington Medical Center
May 16, 2012
Long-Term Follow Up Study for AMD3100 Patients
Completed
- Myeloma
- Telephone Questionnaire
-
Houston, TexasUT MD Anderson Cancer Center
Jul 10, 2012
Multiple Myeloma, Non-Hodgkins Lymphoma Trial in New York (Plerixafor)
Unknown status
- Multiple Myeloma
- Non-Hodgkins Lymphoma
- Plerixafor
-
New York, New YorkMount Sinai School of Medicine
Sep 26, 2011
Multiple Myeloma, Plasma Cell Dyscrasia, Lymphoma Trial in Liverpool (Plerixafor and G-CSF)
Unknown status
- Multiple Myeloma
- +3 more
- Plerixafor and G-CSF
-
Liverpool, Merseyside, United KingdomDept of Haematology, University of Liverpool
Aug 20, 2010